A high content imaging assay for identification of Botulinum neurotoxin inhibitors.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4354101)

Published in J Vis Exp on November 14, 2014

Authors

Krishna P Kota1, Veronica Soloveva2, Laura M Wanner3, Glenn Gomba4, Erkan Kiris5, Rekha G Panchal6, Christopher D Kane2, Sina Bavari6

Author Affiliations

1: Perkin Elmer Inc.; Division of Molecular and Translational Sciences, US Army Medical Research Institute of Infectious Diseases; krishna.p.kota.ctr@mail.mil.
2: Henry M. Jackson Foundation; Division of Molecular and Translational Sciences, US Army Medical Research Institute of Infectious Diseases; DoD Biotechnology High Performance Computing Software Applications Institute (BHSAI), Telemedicine and Advanced Technology Research Center (TATRC), US Army Medical Research and Materiel Command (USAMRMC).
3: The Geneva Foundation; Division of Molecular and Translational Sciences, US Army Medical Research Institute of Infectious Diseases.
4: ORISE; Division of Molecular and Translational Sciences, US Army Medical Research Institute of Infectious Diseases.
5: The Geneva Foundation; Frederick National Laboratory for Cancer Research; Division of Molecular and Translational Sciences, US Army Medical Research Institute of Infectious Diseases.
6: Division of Molecular and Translational Sciences, US Army Medical Research Institute of Infectious Diseases.

Articles cited by this

Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis (2013) 3.00

The most poisonous poison. Science (1959) 2.27

Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. Proc Natl Acad Sci U S A (2004) 1.40

Interactions between synaptic vesicle fusion proteins explored by atomic force microscopy. Proc Natl Acad Sci U S A (2003) 1.36

Bimodal modulation of the botulinum neurotoxin protein-conducting channel. Proc Natl Acad Sci U S A (2009) 1.26

Embryonic stem cell-derived neurons are a novel, highly sensitive tissue culture platform for botulinum research. Biochem Biophys Res Commun (2011) 1.17

Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Res (2011) 1.09

A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus. J Med Chem (2011) 0.98

Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies. J Biomol Screen (2009) 0.98

Gaining ground: assays for therapeutics against botulinum neurotoxin. Trends Microbiol (2010) 0.94

Pharmacophore Refinement Guides the Rational Design of Nanomolar-Range Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease. ACS Med Chem Lett (2010) 0.89

Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A. Biochem Biophys Res Commun (2011) 0.87

The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease. Eur J Med Chem (2012) 0.84